Abstract:Objective: Inflammatory processes have been implicated in the mechanisms of reperfusion injury. The migration of leukocytes into ischemic tissue on reperfusion, which involves binding to the intercellular adhesion molecule (ICAM) of the endothelial cell, is thought to exacerbate tissue injury. The aim of the present study was to assess the effects of an anti-ICAM-1 antibody on reperfusion-induced injury after late reperfusion in a rat middle cerebral artery occlusion (MCAO) suture model. Methods: The animals were divided into four groups: 1) Group 1 (n = 7), 6 hours of permanent MCAO; 2) Group 2 (n = 7), 3 hours of MCAO followed by 3 hours of reperfusion; 3) Group 3 (n = 6), 6 hours of permanent MCAO and treatment with anti-ICAM-1 antibody (designated 1A29, 1 mg/kg) at 2 hours after onset of MCAO; and 4) Group 4 (n = 6), 3 hours of MCAO followed by 3 hours of reperfusion and 1A29 treatment. During the experiment, regional cerebral blood flow was measured by a laser Doppler flowmetric scanning technique. At the 6-hour time point, all rats were killed, and the results of leukocyte infiltration by myeloperoxidase activity and histological analysis using 2,3,5-triphenyltetrazolium chloride staining were examined. Results: Regional cerebral blood flow values before and after MCAO were not significantly different among the four groups. Regional cerebral blood flow values after reperfusion were not significantly different in the two reperfused groups. The percentage brain injury volumes in both the total and cortical areas and the myeloperoxidase activity in the latter were significantly larger in Group 2 (the reperfused group) than in the other groups (P < 0.05) but were decreased by anti-ICAM-1 antibody treatment (Group 2 versus Group 4, P < 0.05). However, there were no differences between Groups 1 and 3 without reperfusion. Myeloperoxidase activities correlated positively with infarct volumes (P < 0.01). Conclusion: The findings of this study demonstrate that the anti-ICAM antibody treatment is effective at inhibiting early inflammatory processes and reperfusion-induced injury caused by late arterial recanalization, which would contribute to widening the therapeutic window of thrombolytic therapy.

Inhibition Of Tnf Alpha Attenuates Infarct Volume And Icam-1 Expression In Ischemic Mouse Brain

Inhibiting the Na+/H+ Exchanger Reduces Reperfusion Injury: a Small Animal MRI Study.

Minocycline Reduces Intracerebral Hemorrhage-Induced Brain Injury

Expression of Tumor Necrosis Factor-Alpha and Intercellular Adhesion Molecule-1 after Focal Cerebral Ischemia in Interleukin-1Beta Converting Enzyme Deficient Mice.

Attenuation of Temporary Focal Cerebral Ischemic Injury in the Mouse Following Transfection with Interleukin-1 Receptor Antagonist

The protective effects of tumor necrosis factor receptor 1 deletion on hindlimb ischemia

Dual Roles of Tumor Necrosis Factor-Α Receptor-1 in a Mouse Model of Hindlimb Ischemia

Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-beta 1 expression

Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-β1 expression

Inhibition of MyD88 by a Novel Inhibitor Reverses Two-Thirds of the Infarct Area in Myocardial Ischemia and Reperfusion Injury

Abstract 398: Inhibition of Tissue Factor Reduces Thrombosis and Inflammation Without Increased Bleeding in a Mouse Model of Ischemic Stroke

Attenuation of Ischemic Inflammatory Response in Mouse Brain Using an Adenoviral Vector to Induce Overexpression of Interleukin-1 Receptor Antagonist

Expression of Intercellular Adhesion Molecule 1 (ICAM-1) is Reduced in Permanent Focal Cerebral Ischemic Mouse Brain Using an Adenoviral Vector to Induce Overexpression of Interleukin-1 Receptor Antagonist

Experimental study on anti-TNF-alpha monoclonal antibody attenuating skeletal muscle ischemia reperfusion injury

Targeting TNF-α: The therapeutic potential of certolizumab pegol in the early period of cerebral ischemia reperfusion injury in mice

Abstract TMP5: Preexisting Interleukin-10 In Susceptible Cerebral Arteries May Decrease Subsequent Brain Injury Caused By Ischemic/reperfusion

Effects of anti-intercellular adhesion molecule-1 antibody on reperfusion injury induced by late reperfusion in the rat middle cerebral artery occlusion model

Stroke upregulates TNFalpha transport across the blood-brain barrier.

Abstract WP301: STAT3 Inhibition Reduces Infarct and Neuroinflammation in Experimental Stroke

Treatment of NAD+ protects transient middle cerebral artery occlusion in the mouse model of tMCAO

Effects of Tumor Necrosis Factor-Α on Skeletal Muscle Ischemia Reperfusion Injury